Skip to main content
Equibles

AQR CAPITAL MANAGEMENT LLC

Position in FTRE — Fortrea Holdings Inc.

CIK 1167557 Greenwich, CT
Back to FTRE Full portfolio

Position in FTRE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$51,860,244
+$20,789,122 QoQ
Shares Held
2,980,474
-9.6% QoQ
Ownership
3.13%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#9
of 334 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in FTRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $5,658,888,286 across 216 Biotechnology names. FTRE ranks #17 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 1,126,080 $702,155,918
2 INCY
Incyte Corp
 5,320,901 $603,177,333
3 EXEL
Exelixis, Inc.
 11,023,943 $599,812,735
4 JAZZ
Jazz Pharmaceuticals plc
 1,522,568 $366,893,205
5 BMRN
Biomarin Pharmaceutical Inc
 5,699,541 $326,127,732
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 616,170 $306,070,117
7 RVMD
Revolution Medicines, Inc.
 1,295,450 $242,611,869
8 RPRX
Royalty Pharma plc
 4,305,412 $241,404,446

All Filings in FTRE

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $51,860,244 2,980,474
2026-03-31 $31,071,122 3,298,421
2025-12-31 $51,544,049 2,988,061
2025-09-30 $31,452,765 3,735,483
2025-06-30 $32,184,711 6,515,124
2025-03-31 $8,269,376 1,095,282
2024-12-31 $7,245,580 388,503
2024-09-30 $6,286,560 314,328
2024-06-30 $3,361,916 144,041
2024-03-31 $9,410,541 234,443
2023-12-31 $13,397,446 383,881
2023-09-30 $3,953,510 138,283